Technology News and Research

RSS

Comparative study reveals no clinical advantages of mobile bearing knee systems over fixed bearing knee systems

Stryker Corporation's Orthopaedics' division today announced at the American Academy of Orthopaedic Surgeons Conference that its recent FDA-monitored Investigational Device Exemption study found no statistical difference in clinical outcomes between its mobile bearing and traditional fixed bearing knee systems. In contrast, Stryker continues to be very pleased with the success of its fixed bearing Triathlon Knee System with X3 Advanced Bearing Technology, which offers significant advantages over mobile bearing knees on wear rates and overall value.

9 Mar 2010

Obesity - Body's effort to protect organs from lipids' toxic effects

The collection of symptoms that is the metabolic syndrome-insulin resistance, high cholesterol, fatty liver, and a greater risk for diabetes, heart disease, and stroke-are all related to obesity, but, according to a review in the March 9th issue of the Cell Press publication Trends in Endocrinology and Metabolism, not in the way you probably think they are.

9 Mar 2010

Gender inequality killing millions of women in Asia, report finds

"Nearly 100 million women across Asia have 'disappeared' because of a huge and growing gender gap that has fatally deprived them of access to health care and food and has led to widespread abortions of female fetuses, according to a U.N. report released Monday," the Associated Press reports.

9 Mar 2010

X-spine Systems, Gamma Spine announce exclusive agreement for minimally invasive spinal fixation technology

X-spine Systems, Inc., a global manufacturer of implants and instruments for spinal surgery, announced today that it has entered into an exclusive license agreement with Gamma Spine for the development and distribution of its minimally invasive spinal fixation technology. Gamma Spine, founded by Dr. Vijay Goel, Ph.D., will participate in the development process with X-spine.

9 Mar 2010

IEEE, AMA to host conference: Overcoming challenges in individualized healthcare, technological innovations

IEEE, the world's largest technical professional association, and the American Medical Association, are joining together to host the First Conference on Medical Technology and Individualized Healthcare.

9 Mar 2010

California venture capitalist/ philanthropist gifts $6M to Institute for Systems Biology

The Institute for Systems Biology, an independent, non-profit biomolecular research institute, has received a $6 million gift from a California venture capitalist and philanthropist to support strategic organizational objectives.

9 Mar 2010

PDVI launches new web site for tracking dengue fever epidemics

PDVI, a program of the International Vaccine Institute funded by the Bill & Melinda Gates Foundation, announces today the launch of http://www.denguewatch.org, a news hub for tracking dengue fever epidemics worldwide.

9 Mar 2010

Fenwal receives FDA marketing clearance for Amicus blood cell separator

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.

9 Mar 2010

Three researchers to be honored with SBS Award for achievement in biomolecular sciences and lead discovery

The Society for Biomolecular Sciences will honor three researchers for their substantial contributions to the field of drug discovery. Each recipient will accept their award and speak at the SBS 16th Annual Conference & Exhibition in Phoenix, Arizona, April 11-15, 2010.

9 Mar 2010

Orthofix International announces sale of vascular business assets to Covidien

Orthofix International N.V. announced today it has sold the assets of its vascular business, including its AV-Impulse® mechanical compression technology, to Covidien.

9 Mar 2010

ImmunoGen receives FDA orphan drug designation for IMGN901 compound in treatment of MCC

ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.

8 Mar 2010

Replication Medical receives CE mark for GelFix Posterior Spinal Distraction implant

Replication Medical, Inc., a developer of proprietary, hydrogel based products for the spine and other surgical applications, announced today that it has received a CE mark for its GelFix Posterior Spinal Distraction implant. A CE mark is the quality assurance certification requirement recognized by members of the European Union for sales into those countries.

8 Mar 2010

biospace med receives FDA 510(k) clearance for sterEOS 2D/3D workstation for pediatric use in spine applications

biospace med announced today that it has received 510(k) clearance from the FDA to market the Company’s sterEOS 2D/3D workstation for pediatric use in spine applications. The Company’s EOS ultra-low-dose imager previously has been FDA-cleared for use in pediatrics and adults, while sterEOS has previously been FDA-cleared for adult use in spine.

8 Mar 2010

SensAble Technologies' digital dentistry product line receives $8M infusion

SensAble Technologies, Inc®, a leading provider of 3D modeling software, haptic devices and dental restoration design and fabrication solutions, announced that it has received an $8 million investment to propel sales, marketing and engineering efforts for its digital dentistry product line. Existing investor HLM Venture Partners led the round and was joined by North Bridge Venture Partners, both of whom are headquartered in the Boston area, and have extensive expertise with medical device company funding.

8 Mar 2010

iCAD granted patent covering SecondLook Digital CAD solution incorporating lesion metrics

iCAD, Inc., an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, announces that the United States Patent and Trademark Office recently granted the company Patent Number 7,660,448. This patent covers future iterations of iCAD’s SecondLook® Digital Computer-Aided Detection (CAD) solution with potential application to the company’s other image analysis solutions.

8 Mar 2010

MabCure closes private placement, converts bridge loan into equity securities

MabCure, Inc., a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, today announced that it has recently completed a private placement in the aggregate amount of $1 million. The amount is comprised of a $500,000 cash investment and the conversion of a $500,000 bridge loan that was made in September 2009, into equity securities.

8 Mar 2010

Butler Health System to implement Alpha Systems' enterprise EDM solution

Alpha Systems, a premier provider of electronic data and document management solutions, today announced that Butler Health System (Butler), an innovative healthcare provider located in Pennsylvania, has named Alpha Systems their vendor of choice for enterprise electronic document management (EDM) software. This move is designed to improve Butler’s communication across the enterprise while moving the healthcare provider closer to a paperless environment.

8 Mar 2010

Ascension Orthopedics launches PyroTITAN Humeral Resurfacing Arthroplasty System

Ascension Orthopedics, Inc., a leader in orthopedic extremity implants, announces the international market launch of the PyroTITAN™ Humeral Resurfacing Arthroplasty System at the American Academy of Orthopaedic Surgeons Annual Conference in New Orleans, LA, March 9-13, 2010. Designed to meet the unique soft tissue biocompatibility requirements of the shoulder joint, the PyroTITAN humeral resurfacing implant is the first commercially-available, human shoulder arthroplasty prosthesis made of PyroCarbon.

8 Mar 2010

Positive data from Argos Therapeutics' AGS-003 Phase 2 trial for mRCC

Argos Therapeutics today announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium.

8 Mar 2010

Luminetx, Alliance Medical sign exclusive national sales distribution agreement

Luminetx®, a division of Christie Medical Holdings, Inc. and recently acquired by Christie Digital Systems USA, Inc., has signed an exclusive national sales distribution agreement with New Alliance of Independent Medical Distributors, Inc., DBA Alliance Medical. The agreement, effective last month, aligns the medical device company with Alliance Medical, the nation’s largest consortium of specialty medical sales distribution companies for intravenous devices, with comprehensive access to the U.S. acute, oncology and home health markets.

8 Mar 2010

Technology News and Research

Comparative study reveals no clinical advantages of mobile bearing knee systems over fixed bearing knee systems

Obesity - Body's effort to protect organs from lipids' toxic effects

Gender inequality killing millions of women in Asia, report finds

X-spine Systems, Gamma Spine announce exclusive agreement for minimally invasive spinal fixation technology

IEEE, AMA to host conference: Overcoming challenges in individualized healthcare, technological innovations

California venture capitalist/ philanthropist gifts $6M to Institute for Systems Biology

PDVI launches new web site for tracking dengue fever epidemics

Fenwal receives FDA marketing clearance for Amicus blood cell separator

Three researchers to be honored with SBS Award for achievement in biomolecular sciences and lead discovery

Orthofix International announces sale of vascular business assets to Covidien

ImmunoGen receives FDA orphan drug designation for IMGN901 compound in treatment of MCC

Replication Medical receives CE mark for GelFix Posterior Spinal Distraction implant

biospace med receives FDA 510(k) clearance for sterEOS 2D/3D workstation for pediatric use in spine applications

SensAble Technologies' digital dentistry product line receives $8M infusion

iCAD granted patent covering SecondLook Digital CAD solution incorporating lesion metrics

MabCure closes private placement, converts bridge loan into equity securities

Butler Health System to implement Alpha Systems' enterprise EDM solution

Ascension Orthopedics launches PyroTITAN Humeral Resurfacing Arthroplasty System

Positive data from Argos Therapeutics' AGS-003 Phase 2 trial for mRCC

Luminetx, Alliance Medical sign exclusive national sales distribution agreement

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News